-
2
-
-
13144306065
-
-
(a) Yang, L.; Berk, S. C.; Rohrer, S. P.; Mosley, R. T., Guo, L.; Underwood, D. J.; Arison, B. H.; Birzin, E. T.; Hayes, E. C., Mitra, S. W.; Parmar, R. M.; Cheng, K.; Wu, T. J.; Butler, B. S.; Foor, F.; Pasternak, A.; Pan, Y.; Silva, M.; Freidinger, R. M.; Smith, R. G.; Chapman, K.; Schaeffer, J. M.; Patchett, A. A. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 10836-10841.
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 10836-10841
-
-
Yang, L.1
Berk, S.C.2
Rohrer, S.P.3
Mosley, R.T.4
Guo, L.5
Underwood, D.J.6
Arison, B.H.7
Birzin, E.T.8
Hayes, E.C.9
Mitra, S.W.10
Parmar, R.M.11
Cheng, K.12
Wu, T.J.13
Butler, B.S.14
Foor, F.15
Pasternak, A.16
Pan, Y.17
Silva, M.18
Freidinger, R.M.19
Smith, R.G.20
Chapman, K.21
Schaeffer, J.M.22
Patchett, A.A.23
more..
-
3
-
-
0032561511
-
-
(b) Rohrer, S. P.; Birzin, E. T.; Mosley, R. T.; Berk, S. C., Hutchins, S. M.; Shen, D. M.; Xiong, Y.; Hayes, E. C.; Parmar, R. M.; Foor, F.; Mitra, S. W.; Degrado, S. J.; Shu, M.; Klopp, J. M.; Cai, S. J., Blake, A.; Chan, W. W.; Pasternak, A.; Yang, L.; Patchett, A. A.; Smith, R. G.; Chapman, K. T.; Schaeffer, J. M. Science 1998. 282, 737-740.
-
(1998)
Science
, vol.282
, pp. 737-740
-
-
Rohrer, S.P.1
Birzin, E.T.2
Mosley, R.T.3
Berk, S.C.4
Hutchins, S.M.5
Shen, D.M.6
Xiong, Y.7
Hayes, E.C.8
Parmar, R.M.9
Foor, F.10
Mitra, S.W.11
Degrado, S.J.12
Shu, M.13
Klopp, J.M.14
Cai, S.J.15
Blake, A.16
Chan, W.W.17
Pasternak, A.18
Yang, L.19
Patchett, A.A.20
Smith, R.G.21
Chapman, K.T.22
Schaeffer, J.M.23
more..
-
4
-
-
0034801374
-
-
(a) Orner, B. P.; Ernst, J. T.; Hamilton, A. D. J. Am. Chem. Soc. 2001, 123, 5382-5383.
-
(2001)
J. Am. Chem. Soc.
, vol.123
, pp. 5382-5383
-
-
Orner, B.P.1
Ernst, J.T.2
Hamilton, A.D.3
-
5
-
-
0037048711
-
-
(b) Kutzki, O.; Park, H. S.; Ernst, J. T.; Orner, B. P.; Yin, H.; Hamilton, A. D. J. Am. Chem. Soc. 2002, 124, 11838-11839.
-
(2002)
J. Am. Chem. Soc.
, vol.124
, pp. 11838-11839
-
-
Kutzki, O.1
Park, H.S.2
Ernst, J.T.3
Orner, B.P.4
Yin, H.5
Hamilton, A.D.6
-
6
-
-
0034691130
-
-
(c) Wang, J. L.; Liu, D.; Zhang, Z. J.; Shan, S.; Han, X.; Srinivasula, S. M.; Croce, C. M.; Alnemri, E. S.; Huang, Z. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 7124-7129.
-
(2000)
Proc. Natl. Acad. Sci. U.S.A.
, vol.97
, pp. 7124-7129
-
-
Wang, J.L.1
Liu, D.2
Zhang, Z.J.3
Shan, S.4
Han, X.5
Srinivasula, S.M.6
Croce, C.M.7
Alnemri, E.S.8
Huang, Z.9
-
7
-
-
0035150803
-
-
(d) Degterev, A.; Lugovskoy, A.; Cardone, M.; Mulley, B.; Wagner, G.; Mitchison, T.; Yuan, J. Nat. Cell Biol. 2001, 3, 173-182.
-
(2001)
Nat. Cell Biol.
, vol.3
, pp. 173-182
-
-
Degterev, A.1
Lugovskoy, A.2
Cardone, M.3
Mulley, B.4
Wagner, G.5
Mitchison, T.6
Yuan, J.7
-
8
-
-
0035147650
-
-
(e) Tzung, S. P.; Kim, K. M.; Basanes, G.; Gledt, C. D.; Simon, J.; Zimmerberg, J.; Zhang, K. Y. J.; Hockenbery, D. M. Nat. Cell Biol. 2001, 3, 183-191.
-
(2001)
Nat. Cell Biol.
, vol.3
, pp. 183-191
-
-
Tzung, S.P.1
Kim, K.M.2
Basanes, G.3
Gledt, C.D.4
Simon, J.5
Zimmerberg, J.6
Zhang, K.Y.J.7
Hockenbery, D.M.8
-
9
-
-
0036790811
-
-
Asada, S.; Choi, Y.; Yamada, M.; Wang, S. C.; Hung, M. C.; Qin, J.; Uesugi, M. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 12747-12752.
-
(2002)
Proc. Natl. Acad. Sci. U.S.A.
, vol.99
, pp. 12747-12752
-
-
Asada, S.1
Choi, Y.2
Yamada, M.3
Wang, S.C.4
Hung, M.C.5
Qin, J.6
Uesugi, M.7
-
10
-
-
85039678797
-
-
note
-
Poor cell-permeability is often a problem of inhibitors of protein-protein interactions. In our study, we performed cell-based screens to eliminate non-cell-permeable molecules. Details of the cell-based screens are shown in the Supporting Information.
-
-
-
-
11
-
-
0030756675
-
-
The activation domains of VP16 and NF-κB p65 served as an excellent control because both have been reported to be α helical [Uesugi, M.; Nyanguile, O.; Lu, H.; Levine, A. J.; Verdine, G. L. Science 1997, 277, 1310-1313. Schmitz, M. L.; Silva, M. A.; Altman, H.; Czisch, M.; Holak, T. A.; Baeuerle, P. A. J. Biol. Chem. 1994, 269, 25613-256201 and are as potent as ESX is in cells. However, it is possible that adamanolol is not completely specific for the ESX activation domain.
-
(1997)
Science
, vol.277
, pp. 1310-1313
-
-
Uesugi, M.1
Nyanguile, O.2
Lu, H.3
Levine, A.J.4
Verdine, G.L.5
-
12
-
-
0028116117
-
-
The activation domains of VP16 and NF-κB p65 served as an excellent control because both have been reported to be α helical [Uesugi, M.; Nyanguile, O.; Lu, H.; Levine, A. J.; Verdine, G. L. Science 1997, 277, 1310-1313. Schmitz, M. L.; Silva, M. A.; Altman, H.; Czisch, M.; Holak, T. A.; Baeuerle, P. A. J. Biol. Chem. 1994, 269, 25613-256201 and are as potent as ESX is in cells. However, it is possible that adamanolol is not completely specific for the ESX activation domain.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 25613-256201
-
-
Schmitz, M.L.1
Silva, M.A.2
Altman, H.3
Czisch, M.4
Holak, T.A.5
Baeuerle, P.A.6
-
13
-
-
85039689286
-
-
note
-
129-145 for Sur-2 was 12 μM under the same condition (Figure S1).
-
-
-
-
14
-
-
85039689636
-
-
note
-
Complete assignments of the proton signals of adamanolol were achieved through TOCSY, DQF-COSY, and NOESY experiments. A summary of key NOE connectivities is shown in Figure S2.
-
-
-
-
15
-
-
85039688275
-
-
unpublished results
-
A less constrained adamanol derivative that lacks the isopropyl group had no detectable activity in SK-BR3 cells even at 100 μM, supporting the notion that the Z conformation is important for the activity (Uesugi, M.; Shimogawa, H.; Kigoshi, H., unpublished results).
-
-
-
Uesugi, M.1
Shimogawa, H.2
Kigoshi, H.3
|